Moderna Inc. (NASDAQ:MRNA) shares are trading higher Thursday after reports came out the company is going to develop a new vaccine — named mRNA-1073 — which will be a single shot that combines a booster dose of COVID-19 with a booster dose of a flu vaccine.
Moderna shares were trading up 7.81% at $455.92 at last check Thursday afternoon.
Moderna Daily Chart Analysis
What’s Next For Moderna?
Bullish traders want to see the stock continue to consolidate for a time before breaking above pattern resistance. This could cause another leg of a breakout to happen where the stock makes new highs.
Bearish traders would like to see the stock consolidate for a time and drop further, below pattern support. This could then cause a further downward move to happen.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
